Search research articles
Contact Us
Filters
Showing results (1-10 of 67) with videos related to
Page
of 7
Sort By:
Bone Marrow Transplantation
|
July 28, 2022
Measurable residual disease for secondary acute myeloid leukemia prior to allogeneic hematopoietic cell transplantation: does it make a difference?
Firas El Chaer, Karen K Ballen
British Journal of Haematology
|
November 7, 2019
Treatment of acute leukaemia in adult Jehovah's Witnesses
Firas El Chaer, Karen K Ballen
Expert Review of Hematology
|
December 14, 2025
Current treatments, practical management, and emerging investigational therapies for myelofibrosis
Srinivas Tantravahi, Firas El Chaer, Prithviraj Bose
The American Journal of Medicine
|
June 3, 2019
The Reply
Firas El Chaer, Hana M El Sahly
The American Journal of Medicine
|
January 7, 2019
Vaccination in the Adult Patient Infected with HIV: A Review of Vaccine Efficacy and Immunogenicity
Firas El Chaer, Hana M El Sahly
Current Hematologic Malignancy Reports
|
May 1, 2020
MLL-Rearranged Acute Lymphoblastic Leukemia
Firas El Chaer, Michael Keng, Karen K Ballen
Blood
|
July 1, 2022
How I treat and prevent COVID-19 in patients with hematologic malignancies and recipients of cellular therapies
Firas El Chaer, Jeffery J Auletta, Roy F Chemaly
Blood
|
October 21, 2016
How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients
Firas El Chaer, Dimpy P Shah, Roy F Chemaly
Blood
|
February 9, 2023
How I treat AML incorporating the updated classifications and guidelines
Firas El Chaer, Christopher S Hourigan, Amer M Zeidan
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
May 3, 2024
Managing infectious challenges in the age of molecular-targeted therapies for adult hematological malignancies
Manan Shah, Firas El Chaer, Dora Y Ho, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 67) with videos related to
Sort By:
Page
of 7
Bone Marrow Transplantation
|
July 28, 2022
Measurable residual disease for secondary acute myeloid leukemia prior to allogeneic hematopoietic cell transplantation: does it make a difference?
Firas El Chaer, Karen K Ballen
British Journal of Haematology
|
November 7, 2019
Treatment of acute leukaemia in adult Jehovah's Witnesses
Firas El Chaer, Karen K Ballen
Expert Review of Hematology
|
December 14, 2025
Current treatments, practical management, and emerging investigational therapies for myelofibrosis
Srinivas Tantravahi, Firas El Chaer, Prithviraj Bose
The American Journal of Medicine
|
June 3, 2019
The Reply
Firas El Chaer, Hana M El Sahly
The American Journal of Medicine
|
January 7, 2019
Vaccination in the Adult Patient Infected with HIV: A Review of Vaccine Efficacy and Immunogenicity
Firas El Chaer, Hana M El Sahly
Current Hematologic Malignancy Reports
|
May 1, 2020
MLL-Rearranged Acute Lymphoblastic Leukemia
Firas El Chaer, Michael Keng, Karen K Ballen
Blood
|
July 1, 2022
How I treat and prevent COVID-19 in patients with hematologic malignancies and recipients of cellular therapies
Firas El Chaer, Jeffery J Auletta, Roy F Chemaly
Blood
|
October 21, 2016
How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients
Firas El Chaer, Dimpy P Shah, Roy F Chemaly
Blood
|
February 9, 2023
How I treat AML incorporating the updated classifications and guidelines
Firas El Chaer, Christopher S Hourigan, Amer M Zeidan
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
May 3, 2024
Managing infectious challenges in the age of molecular-targeted therapies for adult hematological malignancies
Manan Shah, Firas El Chaer, Dora Y Ho, et al.
Page
of 7